REVMATOLOGIK KASALLIKLARDA BIOLOGIK TERAPIYANING O‘RNI: KLINIK TAJRIBALAR TAHLILI

Abdurahmonov Azizbek Batirovich; Zaripov Sirojiddin Bayjanbayevich; Qodirbergenov Tangribergen Baxodirovich

Vol. 3 No. 5 (2025), Articles

Vol. 3 No. 5 (2025)

REVMATOLOGIK KASALLIKLARDA BIOLOGIK TERAPIYANING O‘RNI: KLINIK TAJRIBALAR TAHLILI

Articles

Published 2025-05-15

Abdurahmonov Azizbek Batirovich⁺⁻
Zaripov Sirojiddin Bayjanbayevich⁺⁻
Qodirbergenov Tangribergen Baxodirovich⁺⁻

Abdurahmonov Azizbek Batirovich

Assistent kafedrasi PVB va endokrinologiya, Urganch filiali TTA Manzil: Xorazm viloyati, Xiva shahri, Qurqam ko'chasi, 2-uy

Zaripov Sirojiddin Bayjanbayevich

Assistent kafedrasi PVB va endokrinologiya, Urganch filiali TTA Manzil: Xorazm viloyati, Urganch shahri, Ibn Sino ko'chasi, 39-uy

Qodirbergenov Tangribergen Baxodirovich

Assistent kafedrasi PVB va endokrinologiya, Urganch filiali TTA Manzil: Xorazm viloyati, Xiva shahri, Omadli ko'chasi, 67A-uy

PDF

DOI

Keywords

revmatologik kasalliklar, biologik terapiya, revmatoid artrit, psoriatik artrit, ankilozlovchi spondilit, klinik tadqiqotlar, yalligʻlanish, immun tizim, monoklonal antitanachalar, TNF-ingibitorlar, dori samaradorligi, nojo‘ya taʼsirlar.

How to Cite

REVMATOLOGIK KASALLIKLARDA BIOLOGIK TERAPIYANING O‘RNI: KLINIK TAJRIBALAR TAHLILI. (2025). Journal of Universal Science Research, 3(5), 103-108. http://universalpublishings.com/index.php/jusr/article/view/11790

Abstract

Mazkur maqolada revmatologik kasalliklarni davolashda biologik terapiyaning ahamiyati va klinik tajribalarda qoʻllanilishi tahlil qilinadi. Biologik preparatlar organizmdagi yalligʻlanish jarayonlariga bevosita taʼsir etib, revmatoid artrit, psoriatik artrit, ankilozlovchi spondilit kabi surunkali kasalliklarni samarali nazorat qilish imkonini beradi.

PDF

DOI

References

1. Smolen, J. S., et al. (2016). "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs." Annals of the Rheumatic Diseases, 75(1), 96-106.

2. Aletaha, D., et al. (2016). "Disease activity in rheumatoid arthritis: From clinical observations to a conceptual model." Clinical Rheumatology, 35(2), 329-334.

3. Pincus, T., et al. (2017). "Biologic therapies in rheumatoid arthritis: Current status and future directions." Rheumatology International, 37(9), 1333-1341.

4. Kavanaugh, A., et al. (2018). "Psoriatic arthritis: New insights into the treatment of inflammatory arthritis and skin disease." Nature Reviews Rheumatology, 14(9), 572-584.

5. Feldmann, M., & Maini, R. N. (2009). "Biological therapies of rheumatoid arthritis: An overview." Nature Reviews Immunology, 9(5), 355-367.

6. van der Heijde, D., et al. (2015). "The impact of TNF inhibition on the progression of joint damage in rheumatoid arthritis." Rheumatology, 54(1), 2-10.

7. Mease, P. J., et al. (2017). "Biologic agents in psoriatic arthritis: An overview." The Lancet Rheumatology, 3(5), 237-247.

8. Zochling, J., et al. (2015). "Ankylosing spondylitis: Disease pathogenesis, diagnosis, and management." Clinical Rheumatology, 34(3), 423-431.

9. McInnes, I. B., & Schett, G. (2017). "The pathogenesis of rheumatoid arthritis." The New England Journal of Medicine, 376(10), 902-905.

10. Emad, Y., & Taal, W. (2018). "Biologic drugs in the management of rheumatoid arthritis: A critical review." Rheumatology Advances in Practice, 2(1), 1-10.

11. Lee, E. B., et al. (2016). "Clinical trials of biologic agents in the treatment of rheumatoid arthritis." Journal of Clinical Rheumatology, 22(4), 206-212.

12. Gottenberg, J. E., et al. (2017). "Biologic agents and their role in autoimmune diseases." Journal of Autoimmunity, 81, 65-74.

13. Wolfe, F., et al. (2015). "The impact of biologic therapies on quality of life in patients with rheumatoid arthritis." Arthritis Care & Research, 67(8), 1121-1129.